Your account is not claimed yet. You can sign up with ORCID to claim your account.

Cihan Yurdaydin (Cihan Yurdaydın)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

Journal of viral hepatitis

Hepatology international

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Ankara Üniversitesi Tıp Fakültesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ankara Üniversitesi Tıp Fakültesi Sep 1o 1986

Turkey

MD :: GASTROENTEROLOGY

Publications

Terry Cheuk Fung Yip, Cihan Yurdaydin
Improving prediction of hepatocellular carcinoma in chronic hepatitis B by machine learning: Productive relationship of medicine with computer science. Liver international : official journal of the International Association for the Study of the Liver 43 (8) (2023)
Olga Metin, Müjdat Zeybel, Cihan Yurdaydin
Treatment endpoints for chronic hepatitis D. Liver international : official journal of the International Association for the Study of the Liver (2022)
Burak Özbaş, Onur Keskin, Hartmut Hecker, Irfan Karahan, Cansu Özbaş, Çağdaş Kalkan, Aysun Kartal, Fatih Oğuz Önder, Burcu Kahveci Öncü, Genco Gençdal, Murat Akyildiz, Fulya Günşar, Ramazan Idilman, Karin Weissenborn, Ömer Özütemiz, Cihan Yurdaydin
Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatology international 15 (6) (2021)
Cihan Yurdaydin, Onur Keskin, Esra Yurdcu, Aysun Çalişkan, Soner Önem, Fatih Karakaya, Çağdaş Kalkan, Ersin Karatayli, Senem Karatayli, Ingrid Choong, David Apelian, Christopher Koh, Theo Heller, Ramazan Idilman, Mithat A Bozdayi, Jeffrey S Glenn
A Phase ii dose finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis. Hepatology (Baltimore, Md.) (2021)
Genco Gençdal, Müjdat Zeybel, Cihan Yurdaydin
Editorial: natural history of hepatitis delta virus-induced liver disease - less severe today but still needs attention. Alimentary pharmacology & therapeutics 54 (4) (2021)
Handan Y Tuğsal, Selcen Yüksel, Gokhan Kabacam, Sami Evirgen, Kubra Akan, Filiz Akyuz, Mine Gulluoglu, Esra Erden, A Mithat Bozdayi, Kubilay Cinar, Ramazan İdilman, Cihan Yurdaydin, Sabahattin Kaymakoglu, Hakan Bozkaya
ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis. Hepatology forum 2 (1) (2021)
Lisa Sandmann, Cihan Yurdaydin, Katja Deterding, Benjamin Heidrich, Svenja Hardtke, Patrick Lehmann, Birgit Bremer, Michael P Manns, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy, null null
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta. Hepatology communications (2021)
Anika Wranke, Svenja Hardtke, Benjamin Heidrich, George Dalekos, Kendal Yalçin, Fehmi Tabak, Selim Gürel, Yilmaz Çakaloğlu, Ulus S Akarca, Frank Lammert, Dieter Häussinger, Tobias Müller, Michael Wöbse, Michael P Manns, Ramazan Idilman, Markus Cornberg, Heiner Wedemeyer, Cihan Yurdaydin
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta. Journal of viral hepatitis 27 (12) (2020)
Murat Akyıldız, Emel Ahıskalı, Müjdat Zeybel, Cihan Yurdaydin
Regional Epidemiology, Burden, and Management of Hepatitis B Virus in the Middle East. Clinical liver disease 14 (6) (2020)
Onur Keskin, Cihan Yurdaydin
LETTER TO THE EDITOR: Interferon is not an optimal treatment for chronic hepatitis delta but needs 'fair treatment' by us. Hepatology (Baltimore, Md.) (2020)
Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz
Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatology international 14 (5) (2020)
Olympia Evdoxia Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, Georgios Papatheodoridis, Monica Radu, Stephanie Liebig, Heike Bantel, Birgit Bremer, Michael P Manns, Markus Cornberg, Heiner Wedemeyer
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. Journal of viral hepatitis 28 (2) (2020)
Cihan Yurdaydin
New treatment options for delta virus: Is a cure in sight? Journal of viral hepatitis 26 (6) (2019)
Cihan Yurdaydin
Recent advances in managing hepatitis D. F1000Research 6 (2017)

Cihan Yurdaydin.css-eqlu8i{font-size:small;padding-left:4px;} (Cihan Yurdaydın)

Publication Activity (10 Years)

Top Topics

Top Venues

Cihan Yurdaydin (Cihan Yurdaydın)